Combination chemotherapy in sequence for the treatment of L1210 leukemia.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D013713:Teniposide / Q000008:administration & dosage; D013810:Therapeutic Equivalency
D000970:Antineoplastic Agents; D003561:Cytarabine; D004317:Doxorubicin; D003520:Cyclophosphamide; D013713:Teniposide; D008727:Methotrexate